Telomere maintenance and cancer - Look, no telomerase

Nature Reviews Cancer

Volumn 2, Issue 11, 2002, Pages 879-884

  Neumann, Axel A ^a   Reddel, Roger R ^a  

^a CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE LENGTHENING OF TELOMERE INHIBITOR; ANTINEOPLASTIC AGENT; TELOMERASE; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; ENZYME INHIBITOR; RAD52 PROTEIN; RAD52 PROTEIN, HUMAN; RAD52 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN; TUMOR PROTEIN;

CANCER; CANCER CELL CULTURE; CANCER THERAPY; CELL IMMORTALIZATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TELOMERE; APOPTOSIS; BIOLOGICAL MODEL; CELL AGING; CHROMOSOME; DRUG ANTAGONISM; DRUG EFFECT; DYSKERATOSIS CONGENITA; ENZYMOLOGY; GENETIC RECOMBINATION; GENETICS; HUMAN; HUMAN CHROMOSOME; NEOPLASM; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; ULTRASTRUCTURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL AGING; CHROMOSOMES, FUNGAL; CHROMOSOMES, HUMAN; DNA-BINDING PROTEINS; DYSKERATOSIS CONGENITA; ENZYME INHIBITORS; HUMANS; MODELS, GENETIC; NEOPLASM PROTEINS; NEOPLASMS; RAD52 DNA REPAIR AND RECOMBINATION PROTEIN; RECOMBINATION, GENETIC; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TELOMERASE; TELOMERE;

EID: 0036832737     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc929     Document Type: Review

References (83)

1. n, present at the telomeres of human chromosomes. Proc. Natl Acad. Sci. USA 85, 6622-6626 (1988).
2. Blackburn, E. H. Structure and function of telomeres. Nature 350, 569-573 (1991).
3. de Lange, T. Protection of mammalian telomeres, Oncogene 21, 532-540 (2002).
4. Wellinger, R. J., Ethier, K., Labrecque, P. & Zakian, V. A. Evidence for a new step in telomere maintenance. Cell 85, 423-433 (1996).
5. Makarov, V. L., Hirose, Y. & Langmore, J. P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88, 657-666 (1997).
6. Wright, W. E., Tesmer, V. M., Huffman, K. E., Levene, S. D. & Shay, J. W. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 11, 2801-2809 (1997).
7. Griffith, J. D. et al. Mammalian telomeres end in a large duplex loop. Cell 91, 503-514 (1999).
8. Olovnikov, A. M. [Principle of marginotomy in template synthesis of polynucleotides]. Doklady Akademii. Nauk. SSR 201, 1496-1499 (1971).
9. Watson, J. D. Origin of concatemeric T7 DNA. Nature New Biol. 239, 197-201 (1972).
10. Levy, M. Z., Allsopp, R. C., Futcher, A. B., Greider, C. W. & Hadey, C. B. Telomere end-replication problem and cell aging. J. Mol. Biol. 225, 951-960 (1992).
11. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990).
12. Hayflick, L. & Moorhead, P. S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621 (1961).
13. Newbold, R. F., Overell, R. W. & Connell, J. R. Induction of immortality is an early prerequisite event in malignant transformation of mammalian cells by carcinogens. Nature 299, 633-635 (1982).
14. O'Brien, W., Stenman, G. & Sager R. Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc. Natl Acad. Sci. USA 83, 8659-8663 (1986).
15. Rhim, J. S. et al. Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science 227, 1250-1252 (1985).
16. Reddel, R. R. et al. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. Oncogene Res. 3, 401-408 (1988).
17. Girardi, A. J., Jensen, F. C. & Koprowski, H. SV40-induced transformation of human diploid cells: crisis and recovery. J. Cell. Comp. Physiol. 65, 69-84 (1965).
18. Murnane, J. P., Fuller, L. F. & Painter, R. B. Establishment and characterization of a permanent pSV ori-transformed ataxia-telangiectasia cell line. Exp. Cell Res. 158, 119-126 (1985).
19. Bryan, T. M. & Reddel, R. R. SV40-induced immortalization of human cells. Crit. Rev. Oncogenesis 5, 831-857 (1994).
20. Huschtscha, L. I. & Holliday, R. Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts. J. Cell Sci. 83, 77-99 (1988).
21. Shay, J. W. & Wright, W. E. Quantitation of the frequency of immortalization of normal human diploid fibroblasts by SV40 large T-antigen. Exp. Cell Res. 184, 109-118 (1989).
22. McCormick, A. & Campisi, J. Cellular aging and senescence. Curr. Opin. Cell Biol. 3, 230-234 (1991).
23. Counter, C. M. et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929 (1992).
24. Olovnikov, A. M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41, 181-190 (1973).
25. Harley, C. B., Vaziri, H., Counter, C. M. & Allsopp, R. C. The telomere hypothesis of cellular aging Exp. Gerontol. 27, 375-382 (1992).
26. Greider, C. W. & Blackburn, E. H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413 (1985).
27. Halvorsen, T. L., Leibowitz, G. & Levine, F. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol. Cell Biol. 19, 1864-1870 (1999).
28. Counter, C. M. et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl Acad. Sci. USA 95, 14723-14728 (1998).
29. Hahn, W. C. et al. Creation of human tumour cells with defined genetic elements. Nature 400, 464-468 (1999).
30. Murnane, J. P., Sabatier, L., Marder, B. A. & Morgan, W. F. Telomere dynamics in an immortal human cell line. EMBO J. 13, 4953-4962 (1994).
31. Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015 (1994).
32. Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R. R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248 (1995).
33. Bryan, T. M. & Reddel, R. R. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur. J. Cancer. 33, 767-773 (1997).
34. Bryan, T. M., Marusic, L., Bacchetti, S., Namba, M. & Reddel, R. R. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum. Mol. Genet 6, 921-926 (1997).
35. Hande, M. P., Samper, E., Lansdorp, P. & Blasco, M. A. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144, 589-601 (1999).
36. Gollahon, L. S. et al. Telomerase activity during spontaneous immortalization of Li-Fraumeni syndrome skin fibroblasts Oncogene 17, 709-717 (1998).
37. Yeager, T. R. et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179 (1999).
38. Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A. & Reddel, R. R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med. 3, 1271-1274 (1997).
39. Henson, J. D., Neumann, A. A., Yeager, T. R. & Reddel, R. R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610 (2002).
40. Shay, J. W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791 (1997).
41. Reddel, R. R. The role of senescence and immortalization in carcinogenesis. Carcinogenesis 21, 477-484 (2000).
42. Cerone, M. A., Londono-Vallejo, J. A. & Bacchetti, S. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum. Mol. Genet. 10, 1945-1952 (2001).
43. Grobelny, J. V., Kulp-McEliece, M. & Broccoli, D. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Hum. Mol. Genet. 10, 1953-1961 (2001).
44. Perrem, K., Colgin, L. M., Neumann, A. A. Yeager, T. R. & Reddel, R. R. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21, 3862-3875 (2001)
45. Ford, L. P. et al. Telomerase can inhibit the recombination-based pathway of telomere maintenance in human cells. J. Biol. Chem. 276, 32198-32203 (2001).
46. Stewart, S. A. et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl Acad. Sci. USA 99, 12606-12611 (2002).
47. Zhang, X., Mar V., Zhou, W., Harrington, L. & Robinson, M. O. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13, 2388-2399 (1999).
48. Hahn, W. C. et al. Inhibition of telomerase limits the growth of human cancer cells. Nature Med. 5, 1164-1170 (1999).
49. Herbert, B.-S. et al. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl Acad. Sci. USA 96, 14276-14281 (1999).
50. Damm, K. et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958-6968 (2001).
51. Collins, K. & Mitchell, J. R. Telomerase in the human organism. Oncogene 21, 564-579 (2002).
52. Dokal, I. Dyskeratosis congenita in all its forms. Br. J. Haematol. 110, 768-779 (2000).
53. Herrera, E., Martinez, C. & Blasco, M. A. Impaired germinal center reaction in mice with short telomeres. EMBO J. 19, 472-481 (2000).
54. 1- senescence Cell 73, 347-360 (1993).
55. Rizki, A. & Lundblad, V. Defects in mismatch repair promote telomerase-independent proliferation. Nature 411, 713-716 (2001).
56. Nautiyal, S., DeRisi, J. L. & Blackburn, E. H. The genome-wide expression response to telomerase deletion in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 99, 9316-9321 (2002).
57. Teng, S.-C. & Zakian, V. A. Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol. 19, 8083-8093 (1999).
58. Niida, H. et al. Telomere maintenance in telomerase-deficient mouse embryonic stem cells: characterization of an amplified telomeric DNA. Mol. Cell. Biol. 20, 4115-4127 (2000).
59. Teng, S.-C., Chang, J., McCowan, B. & Zakian, V. A. Telomerase-independent lengthening of yeast telomeres occurs by an abrupt Rad50p-dependent, Rif-inhibited recombinational process. Mol. Cell 6, 947-952 (2000).
60. Le, S., Moore, J. K., Haber, J. E. & Greider, C. W. RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics 152, 143-152 (1999).
61. Chen, Q., Ijpma, A. & Greider, C. W. Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol. Cell. Biol. 21, 1819-1827 (2001).
62. Huang, P.-H. et al. SGS1 is required for telomere elongation in the absence of telomerase. Curr. Biol. 11, 125-129 (2001).
63. Cohen, H. & Sinclair, D. A. Recombination-mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase. Proc. Natl Acad. Sci. USA 98, 3174-3179 (2001).
64. Johnson, F. B. et al. The Saccharomyces cerevisiae WRN homolog Sgs1 p parlicipates in telomere maintenance in cells lacking telomerase. EMBO J. 20, 905-913 (2001).
65. Reddel, R. R., Bryan, T. M. & Murnane, J. P. Immortalized cells with no detectable telomerase activity. A review. Biochemistry 62, 1254-1262 (1997).
66. Grobelny, J. V., Godwin, A. K. & Broccoli, D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G2/M phase of the cell cycle. J. Cell Sci. 113, 4577-4585 (2000).
67. Negorev, D. & Maul, G. G. Cellular proteins locaiized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot. Oncogene 20, 7234-7242 (2001).
68. Dunham, M. A., Neumann, A. A., Fasching, C. L. & Reddel, R. R. Telomere maintenance by recombination in human cells. Nature Genet. 26, 447-450 (2000).
69. Varley, H., Pickett, H. A., Foxon, J. L., Reddel, R. R. & Royle, N. J. Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells. Nature Genet. 30, 301-305 (2002).
70. Natarajan, S. & McEachern, M. J. Recombinational telomere elongation promoted by DNA circles. Mol. Cell. Biol. 22, 4512-4521 (2002).
71. Tokutake, Y. et al. Extra-chromosome telomere repeat DNA in telomerase-negative immortalized cell lines. Biochem. Biophys. Res. Commun. 247, 765-772 (1998).
72. Ogino, H. et al. Release of telomeric DNA from chromosomes in immortal human cells lacking telomerase activity. Biochem. Biophys. Res. Commun. 248, 223-227 (1998).
73. Rosen, M., Kamnert, I. & Edstrom, J. E. Extrachromosomal RNA-DNA complex containing long telomeric repeats in chironomids. Insect Mol. Biol. 11, 167-174 (2002).
74. Perrem, K. et al. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18, 3383-3390 (1999).
75. Ishii, Y., Tsuyama, N., Maeda, S., Tahara, H. & Ide, T. Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality. Mech. Ageing Dev. 110, 175-193 (1999).
76. Yu, X., Jacobs, S. A., West, S. C., Ogawa, T. & Egelman, E. H. Domain structure and dynamics in the helical filaments formed by RecA and Rad51 on DNA. Proc. Natl Acad. Sci. USA 98, 8419-8424 (2001).
77. Roth, C. W., Kobeski, F., Walter, M. F. & Biessmann, H. Chromosome end elongation by recombination in the mosquito Anopheles gambiae. Mol. Cell. Biol. 17, 5176-5183 (1997).
78. López, C. C., Nielsen, L. & Edström, J.-E. Terminal long tandem repeats in chromosomes form Chironomus pallidivittatus. Mol. Cell. Biol. 16, 3285-3290 (1996).
79. Biessmann, H. et al. Addition of teiomere-associated HeT DNA sequences 'heals' broken chromosome ends in Drosophila. Cell 61, 663-673 (1990).
80. Mason, J. M. & Biessmann, H. The unusual telomeres of Drosophila. Trends Genet. 11, 58-62 (1995).
81. Blasco, M. A. Telomerase beyond telomeres. Nature Rev. Cancer 2, 627-633 (2002).
82. Scheel, C. et al. Alternative lengthening of telomeresis associated with chromosomal instability in osteosarcomas. Oncogene 20, 3835-3844 (2001).
83. Lundblad, V. Telomere maintenance without telomerase. Oncogene 21, 522-531 (2002).